Correction to: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes

Yvette N. Lamb; Yahiya Y. Syed

首页> 外文期刊>BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy >Correction to: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes

【24h】

Correction to: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes

机译：校正：LY2963016胰岛素甘草：1型和2型糖尿病的综述

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Abstract Page 91, abstract, lines 1–6 : The following sentence, which previously read:

机译：摘要第91页，摘要，第1-6行：以下句子，以前读过：

著录项

来源
《BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy》 |2018年第2期|共1页
作者
Yvette N. Lamb; Yahiya Y. Syed;
展开▼
作者单位

Springer;

Springer;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类医学免疫学;
关键词

相似文献

外文文献
中文文献
专利

1. Correction to: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes [J] . Yvette N. Lamb, Yahiya Y. Syed BioDrugs: Clinical immunotherapeutics, biopharmaceuticals, and gene therapy . 2018,第2期

机译：校正：LY2963016胰岛素甘草：1型和2型糖尿病的综述
2. Duration of action of two insulin glargine products, LY2963016 insulin glargine and Lantus insulin glargine, in subjects with type 1 diabetes mellitus [J] . Linnebjerg Helle, Lam Eric Chen Quin, Zhang Xin, Diabetes, obesity & metabolism . 2017,第1期

机译：两种胰岛素狼原体产品的持续时间，LY2963016胰岛素狼狼和兰花胰岛素甘草，患有1型糖尿病的受试者
3. Efficacy and safety of LY2963016 insulin glargine in patients with type 1 and type 2 diabetes previously treated with insulin glargine [J] . Hadjiyianni I., Dahl D., Lacaya L. B., Diabetes, obesity & metabolism . 2016,第4期

机译：LY2963016甘精胰岛素在先前接受甘精胰岛素治疗的1型和2型糖尿病患者中的疗效和安全性
4. Switching to insulin glargine 300 U/mL from other basal insulin analogues provides less 24-hour glucose variability in hospitalized patients with type 1 diabetes [C] . V.V. Klimontov, E.A. Koroleva, O.N. Fazullina International Multiconference Bioinformatics of Genome Regulation and StructureSystems Biology . 2018

机译：从其他基础胰岛素类似物转换为甘精胰岛素300 U / mL可使住院的1型糖尿病患者的24小时葡萄糖变异性降低
5. Physiology and pharmacology of diabetes therapies in the cat: Insulin detemir, insulin glargine, exenatide and the incretin effect. [D] . Gilor, Chen. 2010

机译：猫的糖尿病疗法的生理和药理作用：地特胰岛素，甘精胰岛素，艾塞那肽和肠降血糖素作用。
6. Duration of action of two insulin glargine products LY2963016 insulin glargine and Lantus insulin glargine in subjects with type 1 diabetes mellitus [O] . Helle Linnebjerg, Eric Chen Quin Lam, Xin Zhang, -1

机译：两种胰岛素甘精胰岛素产品LY2963016甘精胰岛素和Lantus甘精胰岛素在1型糖尿病患者中的作用持续时间
7. Evaluation of immunogenicity of LY2963016 insulin glargine compared with L antus® insulin glargine in patients with type 1 or type 2 diabetes mellitus [O] . L. L. Ilag, M. A. Deeg, T. Costigan, 2016

机译：Ly2963016胰岛素狼犬的免疫原性评价与1型或2型糖尿病患者的Lant®胰岛素糖尿针相比

Correction to: LY2963016 Insulin Glargine: A Review in Type 1 and 2 Diabetes

摘要

著录项

相似文献

相关主题

期刊订阅